Analysts: Seattle biotechs ready for economic downturn

01/25/2009 | Seattle Times, The

Biotech startups in Seattle that focus on research appear prepared to withstand the economic crisis, analysts said. Among these firms are Accelerator, an incubator that established three companies, and VLST, which signed a drug-development deal with Novo Nordisk in December.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care